Adia Med Inc (ADIA)
OTCMKTS · Delayed Price · Currency is USD
0.1450
-0.0050 (-3.33%)
At close: Aug 28, 2026
Adia Med Company Description
Adia Med Inc operates as a clinical-stage regenerative medicine company.
The company offers products and services focused on stem cell therapies, regenerative medicine treatments, and clinical research in areas such as aesthetics, orthopedics, and autoimmune diseases.
In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels.
The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026.
Adia Med Inc is based in Winter Park, Florida.
Adia Med Inc
| Country | United States |
| Founded | 1999 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Larry Powalisz |
Contact Details
Address: 1561 West Fairbanks Avenue Winter Park, Florida 32789 United States | |
| Phone | 321-231-2843 |
| Website | adiamed.com |
Stock Details
| Ticker Symbol | ADIA |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US00687W1099 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Larry Powalisz | Chief Executive Officer, President, Secretary and Chairman |
| Rebecca Miller | Chief Financial Officer |
| Jenny Angeloff Singhal | Co-Founder |
| April Nugent | Co-Founder |
| Dawn Bell | Chief Revenue Officer |